Literature DB >> 18814009

Sexual function after sacrospinous fixation for vaginal vault prolapse: bad or mad?

Marc Baumann1, Claudia Salvisberg, Michel Mueller, Annette Kuhn.   

Abstract

BACKGROUND: The main indication for sacrospinous ligament suspension is to correct either total procidentia, a posthysterectomy vaginal vault prolapse with an associated weak cardinal uterosacral ligament complex, or a posthysterectomy enterocele. This study aimed to evaluate sexual function and anatomic outcome for patients after sacrospinous ligament suspension.
METHODS: For this study, 52 patients who had undergone sacrospinous ligament fixation during the preceding 5 years were asked to complete the Female Sexual Function Index (FSFI) questionnaire. The patients were vaginally examined using the ICS POP score, and the results were compared with their preoperative status. For statistical analysis, GraphPad for Windows, version 4.0, was used.
RESULTS: The 52 patients were examined during a follow-up period of 38 months. No major intraoperative complications were noted. Recurrence of symptomatic apical descent was noted in 6% of the patients and de novo prolapse in 13.5%. Only one patient was symptomatic. Three patients experienced de novo dyspareunia, which resolved in two cases after stitch removal. Sexual function was good, rating higher than three points for each of the domains including satisfaction, lubrication, desire, orgasm, and pain.
CONCLUSION: Sacrospinous ligament fixation still is a valuable option for the treatment of vaginal vault prolapse. Sexual function is satisfactory, with few cases of de novo dyspareunia.

Entities:  

Mesh:

Year:  2008        PMID: 18814009     DOI: 10.1007/s00464-008-0108-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  26 in total

Review 1.  The G-spot: a modern gynecologic myth.

Authors:  T M Hines
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

2.  Sex and aging.

Authors:  John H J Bancroft
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

3.  Sexual function after sacrospinous ligament fixation for vaginal vault prolapse.

Authors:  R L Holley; R E Varner; B P Gleason; L A Apffel; S Scott
Journal:  J Reprod Med       Date:  1996-05       Impact factor: 0.142

4.  Intraligamentous nerves as a potential source of pain after sacrospinous ligament fixation of the vaginal apex.

Authors:  P A Barksdale; R F Gasser; C M Gauthier; T E Elkins; L L Wall
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

5.  Sacrospinous ligament fixation for eversion of the vagina.

Authors:  G W Morley; J O DeLancey
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

6.  An anatomic evaluation of the sacrospinous ligament colpopexy.

Authors:  L M Kettel; R M Hebertson
Journal:  Surg Gynecol Obstet       Date:  1989-04

7.  Long-term results following fixation of the vagina on the sacrospinal ligament by the vaginal route (vaginaefixatio sacrospinalis vaginalis).

Authors:  K Richter; W Albrich
Journal:  Am J Obstet Gynecol       Date:  1981-12-01       Impact factor: 8.661

8.  Sacrospinous ligament fixation at the time of transvaginal hysterectomy.

Authors:  S H Cruikshank; D W Cox
Journal:  Am J Obstet Gynecol       Date:  1990-06       Impact factor: 8.661

9.  Recurrent pelvic support defects after sacrospinous ligament fixation for vaginal vault prolapse.

Authors:  R L Holley; R E Varner; B P Gleason; L A Apffel; S Scott
Journal:  J Am Coll Surg       Date:  1995-04       Impact factor: 6.113

10.  Sacrospinous cervicocolpopexy with uterine conservation for uterovaginal prolapse in elderly women: an evolving concept.

Authors:  M Hefni; T El-Toukhy; J Bhaumik; E Katsimanis
Journal:  Am J Obstet Gynecol       Date:  2003-03       Impact factor: 8.661

View more
  1 in total

1.  The resurrection of sacrospinous fixation: unilateral apical sling hysteropexy.

Authors:  Dmitry Shkarupa; Nikita Kubin; Ekaterina Shapovalova; Anastasya Zaytseva
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.